First Mercantile Trust Co. decreased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 30.9% during the second quarter, Holdings Channel reports. The institutional investor owned 18,670 shares of the medical instruments supplier’s stock after selling 8,330 shares during the period. First Mercantile Trust Co.’s holdings in DENTSPLY SIRONA were worth $1,211,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of XRAY. BlackRock Inc. boosted its position in shares of DENTSPLY SIRONA by 3,103.7% in the first quarter. BlackRock Inc. now owns 13,891,329 shares of the medical instruments supplier’s stock valued at $867,376,000 after buying an additional 13,457,730 shares in the last quarter. Principal Financial Group Inc. boosted its position in shares of DENTSPLY SIRONA by 1,445.2% in the first quarter. Principal Financial Group Inc. now owns 5,292,885 shares of the medical instruments supplier’s stock valued at $330,488,000 after buying an additional 4,950,337 shares in the last quarter. Clearbridge Investments LLC boosted its position in shares of DENTSPLY SIRONA by 34.6% in the first quarter. Clearbridge Investments LLC now owns 5,258,060 shares of the medical instruments supplier’s stock valued at $328,313,000 after buying an additional 1,353,040 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in shares of DENTSPLY SIRONA during the first quarter valued at $64,184,000. Finally, Renaissance Technologies LLC boosted its position in shares of DENTSPLY SIRONA by 246.0% in the first quarter. Renaissance Technologies LLC now owns 1,044,558 shares of the medical instruments supplier’s stock valued at $65,222,000 after buying an additional 742,700 shares in the last quarter. 95.17% of the stock is owned by institutional investors.

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) opened at 55.33 on Friday. The firm’s market cap is $12.69 billion. DENTSPLY SIRONA Inc. has a 12-month low of $54.49 and a 12-month high of $65.68. The stock has a 50 day moving average price of $62.91 and a 200 day moving average price of $62.30.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.65. The firm had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The business’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.76 EPS. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post $2.73 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be paid a $0.0875 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.35 dividend on an annualized basis and a yield of 0.63%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -10.09%.

COPYRIGHT VIOLATION WARNING: This piece was reported by Daily Political and is the property of of Daily Political. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/08/12/first-mercantile-trust-co-decreases-stake-in-dentsply-sirona-inc-xray.html.

Several equities analysts have recently weighed in on XRAY shares. Goldman Sachs Group, Inc. (The) cut shares of DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and decreased their price target for the stock from $60.00 to $55.00 in a research note on Tuesday, May 23rd. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Wednesday, April 19th. Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research note on Tuesday, May 23rd. HC Wainwright started coverage on shares of DENTSPLY SIRONA in a research note on Tuesday, July 11th. They set a “buy” rating and a $74.00 price target for the company. Finally, BidaskClub raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, June 30th. Two analysts have rated the stock with a sell rating, three have given a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $66.75.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.